| Donald Scott Hogue, CRNA | |
|
1000 1st St N, Alabaster, AL 35007-8703 | |
| (205) 620-8948 | |
| Not Available |
| Full Name | Donald Scott Hogue |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 17 Years |
| Location | 1000 1st St N, Alabaster, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073795118 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 1-068358 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Vincent's Chilton | Clanton, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southern Perioperative Services P C | 9234041815 | 45 |
News Archive
Hemorrhage volume is an important predictor of long-term outcomes in children who survive hemorrhagic stroke, a study shows.
Senesco Technologies, Inc. reported today the completion of cohort 3 of its Phase 1b/2a clinical trial for its drug, SNS01-T, for the treatment of multiple myeloma and lymphoma. The Company has also received approval from its Data Review Committee to proceed to cohort 4, which is expected to require six evaluable patients.
Latest global estimates illustrate the vast impact of the two most common chronic respiratory diseases, with 3.2 million deaths from chronic obstructive pulmonary disease (COPD) and 0.4 million deaths caused by asthma in 2015, according to a new Global Burden of Disease study published in The Lancet Respiratory Medicine journal.
An herbal medicinal substance, Crataegus Extract WS:1442, safely extends the lives of congestive heart failure patients already receiving pharmacological treatment for the disease, according to a study presented at the American College of Cardiology's 56th Annual Scientific Session.
› Verified 8 days ago
| Entity Name | Southern Perioperative Services P C |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740233394 PECOS PAC ID: 9234041815 Enrollment ID: O20031103000290 |
News Archive
Hemorrhage volume is an important predictor of long-term outcomes in children who survive hemorrhagic stroke, a study shows.
Senesco Technologies, Inc. reported today the completion of cohort 3 of its Phase 1b/2a clinical trial for its drug, SNS01-T, for the treatment of multiple myeloma and lymphoma. The Company has also received approval from its Data Review Committee to proceed to cohort 4, which is expected to require six evaluable patients.
Latest global estimates illustrate the vast impact of the two most common chronic respiratory diseases, with 3.2 million deaths from chronic obstructive pulmonary disease (COPD) and 0.4 million deaths caused by asthma in 2015, according to a new Global Burden of Disease study published in The Lancet Respiratory Medicine journal.
An herbal medicinal substance, Crataegus Extract WS:1442, safely extends the lives of congestive heart failure patients already receiving pharmacological treatment for the disease, according to a study presented at the American College of Cardiology's 56th Annual Scientific Session.
› Verified 8 days ago
| Entity Name | Anesthesiologists Associated Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851371850 PECOS PAC ID: 6204739519 Enrollment ID: O20040202000465 |
News Archive
Hemorrhage volume is an important predictor of long-term outcomes in children who survive hemorrhagic stroke, a study shows.
Senesco Technologies, Inc. reported today the completion of cohort 3 of its Phase 1b/2a clinical trial for its drug, SNS01-T, for the treatment of multiple myeloma and lymphoma. The Company has also received approval from its Data Review Committee to proceed to cohort 4, which is expected to require six evaluable patients.
Latest global estimates illustrate the vast impact of the two most common chronic respiratory diseases, with 3.2 million deaths from chronic obstructive pulmonary disease (COPD) and 0.4 million deaths caused by asthma in 2015, according to a new Global Burden of Disease study published in The Lancet Respiratory Medicine journal.
An herbal medicinal substance, Crataegus Extract WS:1442, safely extends the lives of congestive heart failure patients already receiving pharmacological treatment for the disease, according to a study presented at the American College of Cardiology's 56th Annual Scientific Session.
› Verified 8 days ago
| Entity Name | Huntsville Hospital Anesthesia |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851321079 PECOS PAC ID: 7315990751 Enrollment ID: O20050225000538 |
News Archive
Hemorrhage volume is an important predictor of long-term outcomes in children who survive hemorrhagic stroke, a study shows.
Senesco Technologies, Inc. reported today the completion of cohort 3 of its Phase 1b/2a clinical trial for its drug, SNS01-T, for the treatment of multiple myeloma and lymphoma. The Company has also received approval from its Data Review Committee to proceed to cohort 4, which is expected to require six evaluable patients.
Latest global estimates illustrate the vast impact of the two most common chronic respiratory diseases, with 3.2 million deaths from chronic obstructive pulmonary disease (COPD) and 0.4 million deaths caused by asthma in 2015, according to a new Global Burden of Disease study published in The Lancet Respiratory Medicine journal.
An herbal medicinal substance, Crataegus Extract WS:1442, safely extends the lives of congestive heart failure patients already receiving pharmacological treatment for the disease, according to a study presented at the American College of Cardiology's 56th Annual Scientific Session.
› Verified 8 days ago
| Entity Name | Medical West Hospital Authority, An Affiliate Of Uab Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952483729 PECOS PAC ID: 6406865427 Enrollment ID: O20061204000666 |
News Archive
Hemorrhage volume is an important predictor of long-term outcomes in children who survive hemorrhagic stroke, a study shows.
Senesco Technologies, Inc. reported today the completion of cohort 3 of its Phase 1b/2a clinical trial for its drug, SNS01-T, for the treatment of multiple myeloma and lymphoma. The Company has also received approval from its Data Review Committee to proceed to cohort 4, which is expected to require six evaluable patients.
Latest global estimates illustrate the vast impact of the two most common chronic respiratory diseases, with 3.2 million deaths from chronic obstructive pulmonary disease (COPD) and 0.4 million deaths caused by asthma in 2015, according to a new Global Burden of Disease study published in The Lancet Respiratory Medicine journal.
An herbal medicinal substance, Crataegus Extract WS:1442, safely extends the lives of congestive heart failure patients already receiving pharmacological treatment for the disease, according to a study presented at the American College of Cardiology's 56th Annual Scientific Session.
› Verified 8 days ago
| Entity Name | Athens And Limestone County Healthcare Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093951188 PECOS PAC ID: 3870641863 Enrollment ID: O20090430000504 |
News Archive
Hemorrhage volume is an important predictor of long-term outcomes in children who survive hemorrhagic stroke, a study shows.
Senesco Technologies, Inc. reported today the completion of cohort 3 of its Phase 1b/2a clinical trial for its drug, SNS01-T, for the treatment of multiple myeloma and lymphoma. The Company has also received approval from its Data Review Committee to proceed to cohort 4, which is expected to require six evaluable patients.
Latest global estimates illustrate the vast impact of the two most common chronic respiratory diseases, with 3.2 million deaths from chronic obstructive pulmonary disease (COPD) and 0.4 million deaths caused by asthma in 2015, according to a new Global Burden of Disease study published in The Lancet Respiratory Medicine journal.
An herbal medicinal substance, Crataegus Extract WS:1442, safely extends the lives of congestive heart failure patients already receiving pharmacological treatment for the disease, according to a study presented at the American College of Cardiology's 56th Annual Scientific Session.
› Verified 8 days ago
| Entity Name | Medstream Anesthesia Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649616160 PECOS PAC ID: 7416198049 Enrollment ID: O20170516000950 |
News Archive
Hemorrhage volume is an important predictor of long-term outcomes in children who survive hemorrhagic stroke, a study shows.
Senesco Technologies, Inc. reported today the completion of cohort 3 of its Phase 1b/2a clinical trial for its drug, SNS01-T, for the treatment of multiple myeloma and lymphoma. The Company has also received approval from its Data Review Committee to proceed to cohort 4, which is expected to require six evaluable patients.
Latest global estimates illustrate the vast impact of the two most common chronic respiratory diseases, with 3.2 million deaths from chronic obstructive pulmonary disease (COPD) and 0.4 million deaths caused by asthma in 2015, according to a new Global Burden of Disease study published in The Lancet Respiratory Medicine journal.
An herbal medicinal substance, Crataegus Extract WS:1442, safely extends the lives of congestive heart failure patients already receiving pharmacological treatment for the disease, according to a study presented at the American College of Cardiology's 56th Annual Scientific Session.
› Verified 8 days ago
| Entity Name | Cahaba Valley Anesthesia Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568974327 PECOS PAC ID: 0648530360 Enrollment ID: O20180127000068 |
News Archive
Hemorrhage volume is an important predictor of long-term outcomes in children who survive hemorrhagic stroke, a study shows.
Senesco Technologies, Inc. reported today the completion of cohort 3 of its Phase 1b/2a clinical trial for its drug, SNS01-T, for the treatment of multiple myeloma and lymphoma. The Company has also received approval from its Data Review Committee to proceed to cohort 4, which is expected to require six evaluable patients.
Latest global estimates illustrate the vast impact of the two most common chronic respiratory diseases, with 3.2 million deaths from chronic obstructive pulmonary disease (COPD) and 0.4 million deaths caused by asthma in 2015, according to a new Global Burden of Disease study published in The Lancet Respiratory Medicine journal.
An herbal medicinal substance, Crataegus Extract WS:1442, safely extends the lives of congestive heart failure patients already receiving pharmacological treatment for the disease, according to a study presented at the American College of Cardiology's 56th Annual Scientific Session.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Donald Scott Hogue, CRNA Po Box 235022, Montgomery, AL 36123-5022 Ph: (334) 386-2051 | Donald Scott Hogue, CRNA 1000 1st St N, Alabaster, AL 35007-8703 Ph: (205) 620-8948 |
News Archive
Hemorrhage volume is an important predictor of long-term outcomes in children who survive hemorrhagic stroke, a study shows.
Senesco Technologies, Inc. reported today the completion of cohort 3 of its Phase 1b/2a clinical trial for its drug, SNS01-T, for the treatment of multiple myeloma and lymphoma. The Company has also received approval from its Data Review Committee to proceed to cohort 4, which is expected to require six evaluable patients.
Latest global estimates illustrate the vast impact of the two most common chronic respiratory diseases, with 3.2 million deaths from chronic obstructive pulmonary disease (COPD) and 0.4 million deaths caused by asthma in 2015, according to a new Global Burden of Disease study published in The Lancet Respiratory Medicine journal.
An herbal medicinal substance, Crataegus Extract WS:1442, safely extends the lives of congestive heart failure patients already receiving pharmacological treatment for the disease, according to a study presented at the American College of Cardiology's 56th Annual Scientific Session.
› Verified 8 days ago
Mrs. Catherine V Rutledge, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 1000 1st St N, Alabaster, AL 35007 Phone: 205-620-8948 Fax: 205-620-7032 | |
Mrs. Sarah Michael Lynch, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 1000 1st Street North, Alabaster, AL 35007 Phone: 205-620-8948 Fax: 205-620-7032 | |
Ms. Angelia Lawson Brown, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 1000 1st Street North, Alabaster, AL 35007 Phone: 205-620-8948 Fax: 205-620-7032 | |
Michael Mcconville, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1000 1st St N, Alabaster, AL 35007 Phone: 877-224-5809 Fax: 334-377-4417 | |
Paul Meadows, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1000 1st St N, Alabaster, AL 35007 Phone: 334-377-4415 Fax: 334-377-4417 | |
Michael W White, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1000 1st Street North, Alabaster, AL 35007 Phone: 205-620-8948 Fax: 205-620-7032 |